sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

February 29, 2020

Study Completion Date

February 28, 2022

Conditions
Wilsons Disease
Interventions
PROCEDURE

Fibroscan

Liver fibrosis will be determined using fibroscan, and reported as changes in the amount of fibrosis in the liver. The fibroscan is a non-invasive procedure

PROCEDURE

Ultrasound

Ultrasound is a non-invasive procedure

DRUG

Galactose

"Galactose elimination capacity is performed to evaluate metabolic liver function.~The metabolic liver function test galactose elimination capacity requires a 6-hour fast, the infusion of galactose, blood sampling from the ear lobe, and collection of urine for 4 hours."

PROCEDURE

Liver biopsy

Histological disease activity at time of diagnosis evaluating if any liver fibrosis

PROCEDURE

Functional hepatic nitrogen clearance

Functional hepatic nitrogen clearance to evaluate metabolic liver function Functional hepatic nitrogen clearance requires a 12-hour fast, two venflons, the infusion of alanine, and urine sampling for 4 hours

Trial Locations (1)

8000

Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

lead

University of Aarhus

OTHER

NCT02702765 - sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis | Biotech Hunter | Biotech Hunter